Affiliation:
1. Department of Oral and Maxillofacial Pathology and Oral Microbiology, Index Institute of Dental Sciences, Indore, Madhya Pradesh, India
2. Department of Prosthodontics and Crown & Bridge, Index Institute of Dental Sciences, Indore, Madhya Pradesh, India
Abstract
AbstractBecause of active advancement in the field of biomedicine, people have in-depth knowledge of biological nature of malignant tumors and are able to recognized the overexpression of different molecules such as vascular endothelial growth factor receptor, cyclin-dependent kinase, and programmed cell death receptor. Presently, various targeted therapeutic drugs are used in different clinical trials in those patients suffering from oral squamous cell carcinoma. In this review, we converse about the various targeted therapeutic drugs and their advancement in the treatment of oral squamous cell carcinoma. This review scrutinizes the existing documentation in the literature related to the targeted therapies for oral squamous cell carcinoma. English language articles were searched in various databases such as PubMed, Scopus, Science Direct, and Google Scholar. The keywords used for searching are “oral squamous cell carcinoma,” “targeted therapy,” and “therapeutic drugs.”
Subject
Literature and Literary Theory,History,Cultural Studies
Reference62 articles.
1. Cancer of the oral cavity and oropharynx;D W Tshering Vogel;Cancer Imaging,2010
2. Global incidence and risk factors of oral cancer;Y Ghantous;Harefuah,2017
3. The role of chronic mucosal trauma in oral cancer: a review of literature;H R Singhvi;Indian J Med Paediatr Oncol,2017
4. Advances in targeted therapy for oral and maxillofacial head and neck squamous cell carcinoma;D Ling;J Oral Maxillofac Surg,2009
5. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity;L Chen;Nat Rev Immunol,2004
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献